Increasing instances of substandard, falsified and counterfeit medical products continue to pose a major challenge to the global healthcare system which is already suffering from the dire impact of COVID-19. To address this issue, ASPA and Messe Frankfurt India will unite leading experts from
MoreTOKYO: Eisai Co., Ltd. announced today that the new drug application for approval of its in-house-discovered and developed orexin receptor
MoreThe MicroRobot 50 microdosing machine is Romaco Macofar’s innovative high-tech solution for filling cytostatic powders into vials. Three anthropomorphic robots
MoreSanner, international manufacturer of pharmaceutical primary packaging and medical technology products, has completed a highly successful business year 2019: with
MoreOver recent weeks and months, CPhI Worldwide – organised by Informa Markets – has been in constant discussions with key
MoreSignificant opportunities identified in growing and processing raw materials in Asia HONG KONG – The Good Food Institute Asia-Pacific (GFI
MorePublishers responsible for tens of thousands of peer-reviewed journals and books have signed an agreement to take a proactive stance
MoreAs demand for medical supplies soars worldwide in the fight against Covid-19, there is a parallel risk of substandard and
MoreIt is anticipated that glaucoma cases will surpass 100 million by 2040, while macular degeneration shall reach nearly 200 million
MoreThe Hague — Professor Ian Bates has been appointed as the director of the FIP Global Pharmaceutical Observatory (FIP-GPO) by the
MoreThe global ophthalmic drugs market is anticipated to grow moderately, at a CAGR of 4.2% during the forecast period (2020-2025). Visual impairments
More